CSF Monoamine Metabolites in Movement Disorders and Normal Aging
- 1 February 1985
- journal article
- retracted article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 42 (2) , 166-169
- https://doi.org/10.1001/archneur.1985.04060020080021
Abstract
Research from JAMA Neurology — CSF Monoamine Metabolites in Movement Disorders and Normal AgingThis publication has 10 references indexed in Scilit:
- Bromocriptine, physostigmine, and neurotransmitter mechanisms in the dystoniasNeurology, 1982
- CLINICAL-APPLICATION OF THE PROBENECID TEST FOR MEASUREMENT OF MONOAMINE TURNOVER IN CNS1981
- Diminished ventricular fluid dopamine metabolites in adult‐onset dystoniaNeurology, 1978
- CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.Journal of Neurology, Neurosurgery & Psychiatry, 1977
- Biochemical aspects of Huntington's chorea.Journal of Neurology, Neurosurgery & Psychiatry, 1977
- HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movementsJournal of the Neurological Sciences, 1973
- Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measuresNeuropharmacology, 1972
- CONCENTRATION OF HOMOVANILLIC ACID AND 5‐HYDROXYINDOLEACETIC ACID IN THE CEREBROSPINAL FLUID AFTER TREATMENT WITH PROBENECID IN PATIENTS WITH DRUG‐INDUCED TARDIVE DYSKINESIAActa Psychiatrica Scandinavica, 1970
- Relationship of Monoamine Metabolites in Human Cerebrospinal Fluid to AgeNature, 1968